Important update regarding proposals for ICD-11
As reported earlier in the thread, there have been three proposals for PVFS, BME and CFS waiting to be reviewed and processed:
The proposal submitted by
Dimmock & Chapman (submitted on March 26, 2017)
The proposal submitted by
Dr Lily Chu on behalf of the IACFS/ME (submitted on March 31, 2017)
The proposal submitted by
Dr Tarun Dua (submitted on November 06, 2017)
( For my August 2018 report see:
Update on the status of the classification of PVFS, ME and CFS for ICD-11: Part Two)
Dr Tarun Dua's proposal:
Dr Tarun Dua is
Medical Officer, Program for Neurological Diseases and Neuroscience, Management of Mental and Brain Disorders, WHO Department of Mental Health and Substance Abuse.
Dr Dua's proposal, which she has stated was submitted on behalf of the now sunsetted
Topic Advisory Group for Neurology, had recommended moving “Myalgic encephalitis/Chronic Fatigue Syndrome (ME/CFS)” [sic] from the
Diseases of the nervous system chapter to the
Symptoms, signs chapter, as a child under
Symptoms, signs or clinical findings of the musculoskeletal system.
If you are not registered with the ICD-11 Proposal platform, you can access Dr Dua's proposal at the end of this PDF:
https://dxrevisionwatch.files.wordpress.com/2018/08/dua1.pdf
You can read the response to Dr Dua's proposal by Dimmock and Chapman here:
Response by Dimmock & Chapman to Dr Tarun Dua proposal of November 6, 2017, February 15, 2018
Important update regarding Dr Dua's proposal for ICD-11
Yesterday, November 19, Dr Dua's proposal was marked as
Rejected by the ICD-11 Proposal Mechanism admins:
Screenshot: Accessed November 20, 2018:
https://icd.who.int/dev11/proposals/f/en#/http://id.who.int/icd/entity/569175314
---------------------------------------------
The decision to Reject Dr Dua's proposal that the terms should be relocated under the Symptoms, signs chapter is accompanied by this Comment from the ICD-11 Proposal Platform admins "Team3 WHO":
https://icd.who.int/dev11/proposals...lGroupId=303c7493-554a-44c8-8e00-bd0c6c4cc6ef
In response to the many proposals on Chronic fatigue syndrome, the WHO Secretariat has conducted a vast amount of research.
Findings: The condition is characterized by chronic, profound, disabling, and unexplained fatigue and coinciding symptoms such as sleep problems or post-exertional malaise. There is no agreement on a reliable diagnostic symptom pattern. The etiology is still being discussed and there is no uniform treatment approach with reliable outcomes. The only constant is the lead symptom ‘fatigue’ that persists over time.
Decision: As a result of this study, the category ‘postviral fatigue’ that is the indexing target, will not be changed as currently there is no evidence to suggest a better place. The entity will retain its name and remain within the Nervous system chapter.
The Medical and Scientific Advisory Committee and the Classification and Statistics Advisory committee supported this decision.
Team3 WHO 2018-Nov-19 - 07:10 UTC
------------------------
If you are not registered with the ICD-11 Proposal platform, you can access a full copy of Dr Dua's proposal and rationale at the end of this PDF:
https://dxrevisionwatch.files.wordpress.com/2018/08/dua1.pdf
You can read the response to Dr Dua's proposal by Dimmock and Chapman here:
Response by Dimmock & Chapman to Dr Tarun Dua proposal of November 6, 2017, February 15, 2018
The proposal submitted by Dimmock and Chapman on March 27, 2017 can be read here:
Proposal: Revision of G93.3 legacy terms for ICD-11
You can read quotes from the WHO's position on potential relocations, here:
Extract from Response to Dr Dua Proposal of November 6 2017: 4. Compliance with WHO standards and other considerations on relocation, Dimmock & Chapman, February 15, 201
------------------------
As you know, I retired from advocacy work in early October, but I continue to monitor the ICD-11 platforms for my own interest.
If there are any changes to the current listing of these terms, which can be viewed below without registration, or if the proposal submitted by Dimmock and Chapman on March 27, 2017 is processed or commented on by WHO admins, MSAC or CSAC, I will post further information:
Blue Platform (ICD-11 "Implementation Version" as released in June 2018):
ICD-11 for Mortality and Morbidity Statistics (Release for 2018):
https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/569175314
Orange Platform (ICD-11 Maintenance):
Foundation Component: https://icd.who.int/dev11/f/en#/http://id.who.int/icd/entity/569175314
Mortality and Morbidity Statistics: https://icd.who.int/dev11/l-m/en#/http://id.who.int/icd/entity/569175314